Nissin Foods Announces 2025 Q3 Financial Results 
FurGPT Strengthens Global Presence Following Multi-Exchange Listings 
Krown Network Surpasses Ethereum & Bitcoin Pre-Launch Velocity Records; 7x ETH’s ICO Pace 
17th Hong Kong International Wine & Spirits Fair wraps up on a high note with over 8,200 buyers 
The 33rd Hong Kong International Optical Fair attracts some 12,000 buyers Sequana Medical Appoints Jackie Fielding, Former Medtronic VP, to its Board of Directors
GHENT, Belgium, Aug. 31, 2021 (GLOBE NEWSWIRE) — Sequana Medical NV (Euronext Brussels: SEQUA, the…
PCI Biotech first half-year 2021 interim results
Oslo (Norway), 31 August 2021 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company,…
Orphazyme reports business highlights and financial results in Interim Report First Half 2021
Orphazyme A/SCompany announcementNo. 21/2021CVR No.: 32266355 Copenhagen, Denmark, August 31, 2021 – Orphazyme A/S (ORPHA.CO; ORPH) (“the Company”), a late-stage…
Burning Rock Reports Second Quarter 2021 Financial Results
GUANGZHOU, China, Aug. 31, 2021 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the…
Operational Highlights and Financial Results for the Year Ended June 30, 2021
NEW YORK, Aug. 30, 2021 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in…
Junshi Biosciences Announces 2021 Interim Financial Results and Provides Corporate Updates
SHANGHAI, China, Aug. 31, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a…
Talis Biomedical Announces CEO Transition
Kim Popovits to serve as interim CEO MENLO PARK, Calif., Aug. 30, 2021 (GLOBE NEWSWIRE)…
SOPHiA GENETICS to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
BOSTON and LAUSANNE, Switzerland, Aug. 30, 2021 (GLOBE NEWSWIRE) — SOPHiA GENETICS SA (Nasdaq: SOPH),…
ERYTECH to Participate in the Citi 16th Annual BioPharma Conference
ERYTECH to Participate in the Citi 16th Annual BioPharma Conference Cambridge, MA (U.S.) and Lyon…
Galapagos announces planned retirement of CEO
Mechelen, Belgium; 30 August 2021, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ:…
Inventiva announces participation at several investor conferences in September 2021
Daix (France), August 30, 2021 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical…
22nd Century Group Enters Global Specialty Hops Market
Geographic Expansion into Europe via the Netherlands BUFFALO, N.Y., Aug. 30, 2021 (GLOBE NEWSWIRE) —…
AXIM® Biotechnologies’ Manufacturing Partner Empowered Diagnostics Files Amended Emergency Use Authorization with FDA for its Rapid COVID-19 Neutralizing Antibody Test in Whole Blood at Point-of-Care Locations
SAN DIEGO, Aug. 30, 2021 (GLOBE NEWSWIRE) — AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,”…
Syneos Health to Present at the 2021 Baird Global Healthcare Conference
MORRISVILLE, N.C., Aug. 30, 2021 (GLOBE NEWSWIRE) — Syneos Health® (Nasdaq:SYNH), the only fully integrated…
XBiotech Announces Addition of Dr. Mark Ziats, M.D. Ph.D. as Medical Director
Dr. Ziats Joins Clinical Team Involved in Launch and Management of Clinical Studies Across Multiple…
ABVC BioPharma Report Updated by Zacks/SCR
FREMONT, CA, Aug. 30, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ:…
Acer Therapeutics to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
NEWTON, Mass., Aug. 30, 2021 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical…
Biomerica expects Completion of Patient Enrollment for its InFoods® Diagnostic-Guided Therapy Irritable Bowel Syndrome Clinical Trial this week
Final patients to compete this double blinded trial by end of October. Top-Line trial results…
Rubius Therapeutics Appoints Jim Jogerst as Chief Business Officer
CAMBRIDGE Mass., Aug. 30, 2021 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage…
Portage Biotech Announces Results for First Quarter of 2022 Fiscal Year
– $29 million raised during quarter with broad institutional support – Proceeds will accelerate advancement…